BD
The startup is developing an ultra-compact proton therapy system that utilizes targeted radiotherapy to precisely irradiate tumors while minimizing damage to surrounding healthy tissues. This technology enables healthcare providers to deliver effective proton cancer treatment at a lower cost, improving patient outcomes.
Updated 3 months ago
Funding
$14.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup is developing an ultra-compact proton therapy system that utilizes targeted radiotherapy to precisely irradiate tumors while minimizing damage to surrounding healthy tissues. This technology enables healthcare providers to deliver effective proton cancer treatment at a lower cost, improving patient outcomes.